Search results
Results from the WOW.Com Content Network
Stem cell treatments for eye disease always seem to be just on the horizon, but real progress is being made. Curing blindness with stem cells – here's the latest science Skip to main content
Michael G. "Mike" May (born 1954) was blinded by a chemical explosion at the age of 3 but regained partial vision in 2000, at 46, after corneal transplantation and a pioneering stem cell procedure by San Francisco ophthalmologist Daniel Goodman. [12] May had a stem-cell transplant in his right eye in 2001 when he was 47, after 40 years of ...
They set out to test the safety of stem cell treatments, but along the way a group of Massachusetts scientists actually improved the vision of their test patients. Researchers at Advanced Cell ...
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. [3]
Blind from retinitis pigmentosa, Gund is Chairman of the Foundation Fighting Blindness and Chief Executive Officer and Chairman of Gund Investment Corporation. [2] He is a former majority owner of the Cleveland Cavaliers (National Basketball Association) and was co-founder and part owner of the San Jose Sharks (National Hockey League). Berman ...
But now a new breakthrough in technology may be able to reverse blindness caused by a traumatic brain injury even to levels of perfect vision. See more related to this story:
Loss of cones leads to full blindness as early as five years old, but may not onset until many years later. There have been multiple hypotheses about how the lack of rod cells can lead to the death of cone cells. Pinpointing a mechanism for RP is difficult because there are more than 39 genetic loci and genes correlated with this disease.
Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]